Literature DB >> 23775895

Oral direct-acting antiviral therapy to prevent reinfection of the liver graft after liver transplantation for hepatitis C virus-related cirrhosis.

Paul Y Kwo, A Joseph Tector.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23775895     DOI： 10.1002/lt.23662

Source DB:  PubMed          Journal:  Liver Transpl        ISSN： 1527-6465            Impact factor:   5.799


× No keyword cloud information.
  3 in total

1.  The future of hepatitis C virus therapeutics.

Authors:  Paul Y Kwo
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-07

2.  Comparison of first- and second-wave DAAs for HCV GT1: efficacy, safety, tolerability, and regimen complexity.

Authors:  Blaire E Burman; Paul Y Kwo; Kris V Kowdley
Journal:  Hepatol Int       Date:  2014-07-09       Impact factor: 9.029

Review 3.  Management of Hepatitis C Before and After Liver Transplantation in the Era of Rapidly Evolving Therapeutic Advances.

Authors:  Chalermrat Bunchorntavakul; K Rajender Reddy
Journal:  J Clin Transl Hepatol       Date:  2014-06-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.